Joe Diaz
Investor Relations, Lethem Partners
Replay available
ImmuCell Corporation (NASDAQ: ICCC) Q3 2025 earnings conference call, held 2025-11-14. Replay captured from the company's public earnings webcast.

Investor Relations, Lethem Partners
Special Advisor to the CEO, EmuCell Corporation
President and CEO, EmuCell Corporation
Chief Financial Officer, EmuCell Corporation
Private Investor
MKH Management
Watch the replay and follow the connected company analysis, news, and investor updates for Immucell Corporation.
WEBVTT 00:00:00.031 -- 00:00:04.797 Good morning and welcome to the ME Cell Corporation Report's third quarter ended September 00:00:04.797 -- 00:00:06.619 30th, 2025, 00:00:06.619 -- 00:00:09.983 unaudited financial results conference call. 00:00:09.983 -- 00:00:13.046 All participants will be in listen-only mode. 00:00:13.046 -- 00:00:17.031 After today's presentation, there will be an opportunity to ask questions. 00:00:17.031 -- 00:00:20.175 Please note this event is being recorded. 00:00:20.175 -- 00:00:23.759 I would now like to turn the conference over to Joe Diaz of Blitzen Partners. 00:00:23.759 -- 00:00:26.069 Please go ahead. 00:00:26.069 -- 00:00:29.153 Thank you, Rocco. Good morning and welcome to everyone. 00:00:29.153 -- 00:00:34.379 As Rocco indicated, my name is Joe Diaz with Lethem Partners. 00:00:34.379 -- 00:00:38.344 We're the investor relations consulting firm for Emucel. 00:00:38.344 -- 00:00:43.490 I want to thank all of you for joining us today to discuss the unaudited financial results 00:00:43.490 -- 00:00:47.973 for the third quarter ended September 30, 2025. 00:00:47.973 -- 00:00:53.203 Listeners are cautioned that statements made by management during the course 00:00:53.203 -- 00:00:58.332 of this call include forward-looking statements, which include any statements that 00:00:58.332 -- 00:01:04.003 refer to the future events or expected future results or predictions 00:01:04.003 -- 00:01:07.261 about steps the company plans to take in the future. 00:01:07.261 -- 00:01:12.232 These statements are not guarantees of performance and are subject to risks and uncertainties 00:01:12.232 -- 00:01:17.344 that could cause actual results, outcomes, or events to differ materially 00:01:17.344 -- 00:01:22.813 from those discussed today. Additional i...